- Adult Immunization
- Hepatology
- Pediatric Immunization
- Screening
- Psychiatry
- Allergy
- Women's Health
- Cardiology
- Pediatrics
- Dermatology
- Endocrinology
- Pain Management
- Gastroenterology
- Geriatrics
- Infectious Disease
- Obesity Medicine
- Rheumatology
- Oncology
- Nephrology
- Neurology
- Pulmonology
Treatment Strategies to Limit Hypoglycemia
Studies summarized in this slide show focus on fine-tuning insulin-containing regimens to enhance glucose control and avoid variability.
Treatment Strategies to Limit Hypoglycemia: 3 Studies At-a-Glance based on presentations at the American Diabetes Association 77th Scientific Sessions, June 9-13, 2017
Summarized in the slides above are studies presented at the ADA 77th Scientific Sessions that examined treatment regimen effects on glycemic control and variability, including comparisons of:⺠Different oral adjuncts to multiple daily insulin⺠Different morning insulins, and⺠Oral antidiabetic regimens before and after addition of basal insulin Links to meeting abstracts are provided in slide captions.
Related Videos
Impact of Social Determinants of Health on Key Cardiometabolic Measures Amplified by New Research
Intermediate Cardiometabolic Risk: Study Author Explains this "Critical Inflection Point"
US Cardiometabolic Health at Alarming Suboptimal Levels, Says Lead Author of New NHANES Analysis
Beyond HbA1c: Take a Global Approach to Type 2 Diabetes Management, Use all the Tools
Lessons Learned from the VA on Delay in Second-line Treatment for Type 2 Diabetes
VA Clinical Investigator Discusses HbA1c, Comorbidities as Markers for T2D Treatment Intensification
DiabetesWise Pro: Side-by-side, Feature-by-feature CGM Comparison, Plus More
Kidney Outcomes with Tirzepatide in T2D: Hiddo Heerspink, PhD, PharmD Highlights SURPASS-4 Analysis
A Guide to Prescribing the Right Diabetes Device for your Patients, with DiabetesWise Pro Developer Korey Hood, PhD
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
